Differential effects of the antifolates methotrexate, aminopterin and trimetrexate on murine haemopoietic progenitor cells

British Journal of Haematology

Volumn 92, Issue 3, 1996, Pages 514-520

  Stromhaug, A ^a   Slordal, L ^a   Warren, D J ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Aminopterin; CFU C; HPP CFU C; Methotrexate; Trimetrexate

Indexed keywords

AMINOPTERIN; FOLIC ACID ANTAGONIST; FOLINIC ACID; METHOTREXATE; TRIMETREXATE;

ANIMAL CELL; ARTICLE; COLONY FORMATION; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0029981697     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.d01-50.x     Document Type: Article

References (24)

1. Balinska, M., Galivan, J. & Coward, J.K. (1981) Efflux of methotrexate and its polyglutamate derivatives from hepatic cells in vitro. Cancer Research, 41, 2751-2756.
2. Bertino, J.R. (1993) Ode to methotrexate. Journal of Clinical Oncology, 11, 5-14.
3. Bogliolo, G.V., Lerza, R.A., Mencoboni, M.P., Saviane, A.G. & Pannacciulli, I.M. (1988) Toxicity of trimetrexate on hemopoietic progenitor cells in normal mice. Anticancer Research, 8, 229-232.
4. Brown, C.H. & Carbone, P.P. (1991) Effects of chemotherapeutic agents on normal mouse bone marrow grown in vitro. Cancer Research, 31, 185-190.
5. Chabner, B.A. & Myers, C.E. (1992) Clinical pharmacology of cancer chemotherapy. Cancer: Principle and Practice of Oncology (ed. by V. DeVita, S. Hellman and S. Rosenberg). p. 350. Lippincott, Philadelphia.
6. Elslager, E.F. & Davoll, J. (1974) Synthesis of fused pyrimidines folate antagonists. Lectures in Heterocyclic Chemistry (ed. by R. Castle and L. Townsend). p. 133. Tetro Corp., Orem, Utah.
7. Fabre, I., Fabre, G. & Goldman, I.D. (1984) Polyglutamation, an important element en methotrexate cytotoxicity and selectivity in tumor versus murine granulocytic progenitor cells in vitro. Cancer Research, 44, 3191-3195.
8. Farber, S., Diamond, L.K., Mercer, R.D., Sylvester, R.F. & Wolff, J.A. (1948) Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopterol-glutamic acid (aminopterin). New England Journal of Medicine, 238, 787-793.
9. Fleming, G.F. & Schilsky, R.L. (1992) Antifolates: the next generation. Seminars in Oncology, 19, 707-719.
10. Goldin, A., Vendetti, J.M., Humphreys, S.R., Dennis, D., Mantel, N. & Greenhouse, S.W. (1955) A quantitative comparison of the antileukemic effectiveness of two folic acid antagonists in mice. Journal of the National Cancer Institute, 15, 1657-1664.
11. Jackson, R.C., Fry, D.W., Boritzki, T.J., Besserer, J.A., Leopold, W.R., Sloan, B.J. & Elslager, E.F. (1984) Biochemical pharmacology of the lipophilic antifolate trimetrexate. Advances in Enzyme Regulation, 22, 187-206.
12. Jolivet, J., Schilsky, R.L., Bailey, B.D. & Drake, J.C. (1982) Synthesis, retention, and biological activity of methotrexate polyglutamates in cultured human breast cancer cells. Journal of Clinical Investigation, 70, 351-360.
13. Lin, J.T. & Bertino, J.R. (1991) Update on trimetrexate, a folate antagonist with antineoplastic and antiprotozoal properties. Cancer Investigation, 9, 159-172.
14. Matherly, L.H., Barlowe, C.K. & Goldman, I.D. (1986) Antifolate polyglutamation and competitive drug displacement at dihydrofolate reductase as important elements in leucovorin rescue in L1210 cells. Cancer Research, 46, 588-593.
15. McCormack, J.J., Heusner, J.J. & Mathews, L.A. (1980) Preclinical studies with 2,4-diamino-5-methyl-6-((3,4,5-trimethoxyanilino)-methyl) quinazoline (NSC 2490081) a 'non-classical' antifolate. (Abstract). Proceedings of the American Association of Cancer Research, 21, 294.
16. Pannacciulli, I., Massa, G., Bogliolo, G., Ghio, R. & Sobrero, A. (1982) Effects of high-dose methotrexate and leucovorin on murine hemopoietic stem cells. Cancer Research, 42, 530-534.
17. Pinedo, H.M., Chabner, B.A., Zaharko, D.S. & Bull, J.M. (1976a) Evidence for early recruitment of granulocyte precursors during high-dose methotrexate infusions in mice. Blood, 48, 301-307.
18. Pinedo, H.M., Zaharko, D.S., Bull, J.M. & Chabner, B.A. (1976b) The reversal of methotrexate cytotoxicity to mouse bone marrow cells by leucovorin and nucleosides. Cancer Research, 36, 4418-4424.
19. Pinedo, H.M., Zaharko, D.S., Bull, J.M. & Chabner, B.A. (1977) The relative contribution of drug concentration and duration of exposure to mouse bone marrow toxicity during continous methotrexate infusion. Cancer Research, 37, 445-450.
20. Schilsky, R.L., Bailey, B.D. & Chabner, B.A. (1980) Methotrexate polyglutamate synthesis by cultured human breast cancer cells. Proceedings of the National Academy of Science of the United States of America, 77, 2919-2922.
21. Seeger, D.R., Smith, J.M. & Hultquist, M.E. (1947) Antagonist for pteroylglutamic acid. Journal of the American Chemical Society, 69, 2567.
22. Stromhaug, A., Warren, D.J. & Slordal, L. (1995) Effect of methotrexate on murine bone marrow cells in vitro: evidence of a reversible antiproliferative action. Experimental Hematology, 23, 439-443.
23. Vogler, W.R., Minigiolo, E.S. & Garwood, F.A. (1973) The effect of methotrexate on granulocytic stem cells and granulopoiesis. Cancer Research, 33, 1628-1633.
24. Warren, D.J. & Slordal, L. (1993) Induction of a reversible block in murine CFU-C differentiation by exposure to nitrous oxide. Experimental Hematology, 21, 345-349.